NVWM LLC’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

NVWM LLC’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-100	Closed	-$1K	–	371
2019 Q3	$1K	Buy	+100	New	+$1.31K	﹤0.01%	351

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NVWM LLC's BLCM Position: Q4 2019 in Review

NVWM LLC sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2019, closing a stake of 100 shares — an estimated $1K sold.

NVWM LLC first reported a position in BLCM in Q3 2019 and held it in 1 quarter. The position peaked at $1K in Q3 2019. 51 funds tracked by Wall St. Rank hold BLCM as of Q4 2019.

NVWM LLC reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
NVWM LLC sold 100 Bellicum Pharmaceuticals, Inc. shares in Q4 2019, an estimated $1K.
NVWM LLC first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2019 and held it in 1 quarter.
NVWM LLC's Bellicum Pharmaceuticals, Inc. position peaked at $1K in Q3 2019.
51 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2019.

Based on NVWM LLC's 13F filing for Q4 2019, filed 7 Feb 2020.